Abstract
Daprodustat is a hypoxia-inducible factor-prolyl hydroxylase inhibitor in development for treatment of anemia of chronic kidney disease. We evaluated ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
